


Pharmaceuticals | Small Cap
Vineet Laboratories Ltd, operating in the Pharmaceuticals & Biotechnology sector, demonstrates a mixed financial performance. The company shows notable strength in solvency and growth, indicating a stable capital structure and significant expansion in key areas like revenue and assets. However, it faces challenges in profitability, efficiency, and coverage, which could impact its long-term sustainability. While the company has managed to grow its assets and revenue substantially, its profitability margins remain thin. The company's ability to service its debt is also a concern. These factors suggest a need for strategic adjustments to enhance overall financial health and competitive positioning. The company's heavy reliance on debt financing and low-profit margins highlight potential vulnerabilities. Continued focus on operational improvements and strategic investments is crucial for sustainable growth and value creation.
Vineet Laboratories Ltd, operating in the Pharmaceuticals & Biotechnology sector, demonstrates a mixed financial performance. The company shows notable strength in solvency and growth, indicating a stable capital structure and significant expansion in key areas like revenue and assets. However, it faces challenges in profitability, efficiency, and coverage, which could impact its long-term sustainability. While the company has managed to grow its assets and revenue substantially, its profitability margins remain thin. The company's ability to service its debt is also a concern. These factors suggest a need for strategic adjustments to enhance overall financial health and competitive positioning. The company's heavy reliance on debt financing and low-profit margins highlight potential vulnerabilities. Continued focus on operational improvements and strategic investments is crucial for sustainable growth and value creation.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-1.75
Industry Median
19.41
Small Cap Median
18.08
P/E RATIO
-1.45
P/B RATIO
2.06
Industry Median
1.98
Small Cap Median
2.03
P/S RATIO
0.39
Industry Median
2.06
Small Cap Median
1.64
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-2.32
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹31.7 as on Feb 20, 2026.
The company's growth shows a varied performance. Revenue has grown substantially. Asset growth is also strong, suggesting significant investments and expansion. However, earnings per share growth is low, indicating that profitability has not kept pace with revenue and asset growth. While the company is expanding, measures to improve profitability and efficiency are necessary to translate growth into enhanced shareholder value.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | N/A | -21.4 | 10.99 | -28.77 | -50.33 |
| Operating Profit Growth Rate | N/A | 62.5 | -38.46 | -12.5 | -328.57 |
| Earnings Per Share (EPS) Growth | -904.17 | 273.06 | -81.11 | -17.65 | -2055.36 |
| Asset Growth Rate | N/A | 22.02 | -12.78 | 0.86 | -18.8 |
| Net Income Growth Rate | N/A | 250 | -85.71 | 0 | -2100 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Vineet Laboratories Ltd | 4.70 | -1.45 | Neutral | -16.00 | -5.28 | -20.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT